Cite
HARVARD Citation
Wollenhaupt, J. et al. (n.d.). THU0185 Tofacitinib, An Oral JAK Inhibitor, in The Treatment of Rheumatoid Arthritis: Safety and Clinical and Radiographic Efficacy in Open-Label, Long-Term Extension Studies over 7 Years. Annals of the rheumatic diseases. p. 252. [Online].